Aurobindo Pharma Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Aurobindo Pharma Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
AUROB.PHARMA

Click to see a quick summary and important updates about this stock!Dismiss

Aurobindo Pharma Ltd.

BSE: 524804, NSE: AUROPHARMA

  • Market Capitalisation info

    ₹26,599 Cr


  • 12 Month Earnings info

    ₹2,111 Cr

  • Price to Earnings info

    12.61

₹454.00

As on 09-Dec-2022 IST

up-down-arrow-4.85-1.06%

  • Prev Close info

    458.85

  • Day's Openinfo

    460.00

  • Today's Highinfo

    461.70

  • Today's Lowinfo

    450.10

  • Today's Volumeinfo

    10,12,624

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Aurobindo Pharma
-38.18 -18.54 -16.25 -35.32 0.62 -7.56 16.74
S&P BSE Healthcare
-10.79 -2.67 1.25 -6.69 20.54 10.76 11.36
S&P BSE Mid Cap
4.51 1.05 0.77 2.29 21.17 8.89 13.95
As on 09-Dec-2022
2021
2020
2019
2018
2017
2016
2015
Aurobindo Pharma
-20.85 101.11 -37.69 7.16 2.79 -24.06 55.43
S&P BSE Mid Cap
39.18 19.87 -3.05 -13.31 48.13 7.97 7.43
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89 0.49 -12.88 15.06

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        Other Details

        Incorporated

        1986

        Chairman

        K Ragunathan

        Managing Director

        K Nithyananda Reddy

        Group

        Aurobindo

        Headquarters

        Hyderabad, Telangana
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹26,598.68 Cr

        • Revenue (TTM) info

          ₹23,786.88 Cr

        • Earnings (TTM) info

          ₹2,111.18 Cr

        • Cash info

          ₹6,471.64 Cr

        • Total Debt info

          ₹2,372.77 Cr

        • Promoters' ownership info

          51.83%

        • Liquidity info

          High

        • 52 Week range info

          ₹450.10 - 742.00

        • Face value info

          ₹1.00

        • Shares outstanding info

          58,59,38,609

        • 10 Years Aggregate:

          CFO: ₹23,188.60 Cr

          EBITDA: ₹34,486.56 Cr

          Net Profit: ₹23,058.01 Cr

        About The Company

        • Business

          Manufacture of allopathic pharmaceutical preparations

        • Incorporated

          1986

        • Chairman

          K Ragunathan

        • Managing Director

          K Nithyananda Reddy

        • Group

          Aurobindo

        • Listing info

          BSE: 524804, NSE: AUROPHARMA

        • Country

          India

        • Headquarters info

          Hyderabad, Telangana

        • Website info

          www.aurobindo.com